Page 47 - CPG - Clinical Practice Guidelines - Management of Cancer Pain
P. 47

Management of Cancer Pain (Second Edition)
                  ZDV QRW VLJQL¿FDQW  7KHUHIRUH  WKHUH ZDV D QHHG IRU GRVH DGMXVWPHQW IRU
                  PRUSKLQH DQG R[\FRGRQH  7KH DYDLODEOH HYLGHQFH ZDV KHWHURJHQHRXV
                  and of low quality. 52, level I

                  ,Q WKH HDUOLHU HGLWLRQ RI 0R+ &3* RQ &DQFHU 3DLQ  LW ZDV VWDWHG WKDW
                  all opioids should be used cautiously and at reduced doses and/or
                                                                     9
                  reduced frequency in patients with renal and/or liver impairment.
                  ‡   2OGHU DGXOWV
                  There is paucity of data on the use of opioids  in older  adults with
                  cancer pain. Advanced age has greater vulnerability with a proportion
                  of this population having  multiple co-morbidities.  Challenges  in pain
                  assessment, concomitant medical conditions, cognitive impairment
                  e.g. dementia, increasing frailty and loss of physiologic reserve may
                  decrease their capacity to deal with pain and its treatment effectively.
                  Polypharmacy  and co-morbid  diseases  may also reduce  the type of
                  available treatment options. 3

                  Effective and safe cancer pain management in older adults requires
                  careful assessment and individualised care.


                  •  In older adults with cancer pain, the general principle of treatment is
                    to start medication at a low dose and titrate slowly.



                  5HFRPPHQGDWLRQ
                  •  In the management of cancer pain for older patients or those with
                    renal/liver impairment:
                    {  All opioids should be used with caution.*
                    {  Adjustment in doses/frequency of opioids should be considered.


                  *Fentanyl is a safer opioid in renal impairment.
                         2SLRLG VLGH HIIHFWV
                  Opioids are generally  well-tolerated  and safe in cancer pain
                             9
                  management.  In a large systematic review of 25 studies, nausea and
                  constipation were most common, whilst vomiting, drowsiness and dry
                  mouth were less frequent. 54, level I
                  There was a dose-effect relationship, where higher rates of AEs were
                  seen with higher opioid starting doses and higher doses after titration,
                  particularly  in morphine. 54, level I   Awareness of these  AEs is vital to
                  ensure compliance and optimal pain control.




                                             29




          e-cpg inside text-Cancer pain-25/5/24.indd   29               09/08/2024   12:09 AM
   42   43   44   45   46   47   48   49   50   51   52